To examine the possibility that the combination of CD44 and CD133 can still represent the marker for some colon cancer stem cells, the SW620 cell line, which showed four defined subpopulations for CD44 and CD133 expression, was selected for further characterization. The gene discussed is PROM1; the disease is malignant colon neoplasm.